Cardiovascular Review
... 23. Know the two av valves24. Name some differences between cardiac muscle and skeletal ...
... 23. Know the two av valves24. Name some differences between cardiac muscle and skeletal ...
Abstrak_Andro
... of infarction, PCI and fibrinolitic. The exclusion criteria were documented atrioventicular block, chronic heart failure, congenital heart disease, valvular heart disease, consumption of amiodaron,verapamil, phonobarbital and propanolol, got cardiac resynchronization therapy. A prolonged QRS duratio ...
... of infarction, PCI and fibrinolitic. The exclusion criteria were documented atrioventicular block, chronic heart failure, congenital heart disease, valvular heart disease, consumption of amiodaron,verapamil, phonobarbital and propanolol, got cardiac resynchronization therapy. A prolonged QRS duratio ...
Word
... [Alternative subhead for hospitals using the full portfolio of Medtronic MRI-conditional cardiac implantable electronic devices: Amplia MRI and Compia MRI CRT-Ds, Evera MRI ICDs, Advisa MRI pacemakers and Reveal LINQ insertable cardiac monitors: Patients with Serious Heart Conditions Now Have Access ...
... [Alternative subhead for hospitals using the full portfolio of Medtronic MRI-conditional cardiac implantable electronic devices: Amplia MRI and Compia MRI CRT-Ds, Evera MRI ICDs, Advisa MRI pacemakers and Reveal LINQ insertable cardiac monitors: Patients with Serious Heart Conditions Now Have Access ...
Name:______ Per.______ Chapter 18: The Cardiovascular System
... Short Answer: 9. On the EKG tracing below, label the P, QRS and T waves and tell what they represent ...
... Short Answer: 9. On the EKG tracing below, label the P, QRS and T waves and tell what they represent ...
Emergency Medicine CME Quiz
... a. Improved cardiac output by increasing heart rate and improving ventricular diastolic filling time. b. Improved cardiac output by decreasing heart rate and improving ventricular systolic filling time. c. Improved cardiac output by decreasing heart rate and improving ventricular diastolic filling t ...
... a. Improved cardiac output by increasing heart rate and improving ventricular diastolic filling time. b. Improved cardiac output by decreasing heart rate and improving ventricular systolic filling time. c. Improved cardiac output by decreasing heart rate and improving ventricular diastolic filling t ...
Atrial Arrhythmias Atrial fibrillation
... with blood and pump. • This rhythm is life-threatening because there is no pulse and complete loss of consciousness. • The ECG shows shapeless, rapid oscillations and there is no hint of organized complexes • A person in VF requires prompt defibrillation to restore the normal rhythm and function of ...
... with blood and pump. • This rhythm is life-threatening because there is no pulse and complete loss of consciousness. • The ECG shows shapeless, rapid oscillations and there is no hint of organized complexes • A person in VF requires prompt defibrillation to restore the normal rhythm and function of ...
UH Case Medical Center first in Ohio to implant new ventricular
... “The device sits inside the heart and takes blood from the right atrium and pushes it through the right side of the heart to the pulmonary artery, assisting the ailing right ventricle in its pumping function,” said Sahil Parikh, MD, Director of the UH Harrington Heart & Vascular Institute Center for ...
... “The device sits inside the heart and takes blood from the right atrium and pushes it through the right side of the heart to the pulmonary artery, assisting the ailing right ventricle in its pumping function,” said Sahil Parikh, MD, Director of the UH Harrington Heart & Vascular Institute Center for ...
causes of heart failure
... Pts who have marked symptoms at rest despite maximal medical therapy. ...
... Pts who have marked symptoms at rest despite maximal medical therapy. ...
Hibernating myocardium
... Treatment - spironolactone • Probably via blockage of aldosterone • May precipitate hyperkalaemia and renal failure ...
... Treatment - spironolactone • Probably via blockage of aldosterone • May precipitate hyperkalaemia and renal failure ...
Heart Failure
... • Pharmacologic and device therapies are effective in preventing SCD and overall mortality in high risk post-MI and HF patients: – Beta-blockers – ACE inhibitors – Aldosterone Receptor Blockade Drugs (HF) – ICD therapy • Prophylactic use of ICD therapy prevents SCD and saves lives in patients with C ...
... • Pharmacologic and device therapies are effective in preventing SCD and overall mortality in high risk post-MI and HF patients: – Beta-blockers – ACE inhibitors – Aldosterone Receptor Blockade Drugs (HF) – ICD therapy • Prophylactic use of ICD therapy prevents SCD and saves lives in patients with C ...
ICD for Primary Prevention of Sudden Cardiac Death ICD for
... of all-cause and cardiac mortality in patients with ischemic and non-ischemic heart diseases. LVEF < 30–35% LVEF has relatively low specificity as a predictor of death from arrhythmia. (2) NYHA functional class : NYHA classes II and III symptoms are much more likely to die of arrhythmia than NYHA cl ...
... of all-cause and cardiac mortality in patients with ischemic and non-ischemic heart diseases. LVEF < 30–35% LVEF has relatively low specificity as a predictor of death from arrhythmia. (2) NYHA functional class : NYHA classes II and III symptoms are much more likely to die of arrhythmia than NYHA cl ...
(Berberine, Red Yeast Rice, Policosanol) in Elderly
... Introduction: Statins are at the forefront of strategies to manage dyslipidemia, although they are not always well tolerated. At 6-7 months after the drug was supplied, discontinuation rates averaged 30%. Alternate agents to statins have been studied. Some nutraceuticals demonstrated an efficacy in ...
... Introduction: Statins are at the forefront of strategies to manage dyslipidemia, although they are not always well tolerated. At 6-7 months after the drug was supplied, discontinuation rates averaged 30%. Alternate agents to statins have been studied. Some nutraceuticals demonstrated an efficacy in ...
Heart Physiology part 1
... You should understand by now that the Physiology of the Heart refers to the function of the heart You need to be familiar with the conduction system of the heart, the cardiac cycle, sounds of the heart, and cardiac out put ...
... You should understand by now that the Physiology of the Heart refers to the function of the heart You need to be familiar with the conduction system of the heart, the cardiac cycle, sounds of the heart, and cardiac out put ...
HeFSSA GP Program 2015 Case 1 Implantable devices
... • Chronic heart failure therapy involves commitment from the doctor, patient and health funder • Attention to detail is fundamental • Although initial rest, removal from work is necessary sometimes for months, the ultimate aim is to return the patient to normal working life, travel and recreation • ...
... • Chronic heart failure therapy involves commitment from the doctor, patient and health funder • Attention to detail is fundamental • Although initial rest, removal from work is necessary sometimes for months, the ultimate aim is to return the patient to normal working life, travel and recreation • ...
cardio 2 - Iowa State University
... electrical signal is transmitted to the ____________________________ which connects the ____________________ and ________________________. The electrical signal continues through the AV bundle also called the _______________________________ into the left and right ___________________ located in the ...
... electrical signal is transmitted to the ____________________________ which connects the ____________________ and ________________________. The electrical signal continues through the AV bundle also called the _______________________________ into the left and right ___________________ located in the ...
Zoltan Papp, M.D., Ph.D., D.Sc. Institute of Cardiology, Clinical
... over left ventricular end-diastolic volume; normal value > 50%). Diastolic heart failure is therefore also often called heart failure with normal ejection fraction (HFNEF) or heart failure with preserved ejection fraction (HFPEF). Patients with diastolic heart failure are usually older than patients ...
... over left ventricular end-diastolic volume; normal value > 50%). Diastolic heart failure is therefore also often called heart failure with normal ejection fraction (HFNEF) or heart failure with preserved ejection fraction (HFPEF). Patients with diastolic heart failure are usually older than patients ...
6. Cardiovascular Worksheet Part I
... 34. What electrical event precedes ventricular systole? ___________________________________________. 35. As the ventricles contract, why do the AV valves close? ______________________________________. 36. What creates the heart sounds? __________________________________________________________. 37. ...
... 34. What electrical event precedes ventricular systole? ___________________________________________. 35. As the ventricles contract, why do the AV valves close? ______________________________________. 36. What creates the heart sounds? __________________________________________________________. 37. ...
Heart Failure 2013
... decreased ejection fraction • Ejection Fraction= percentage of blood left ventricle pumps out with each beat – Normal= 55-70% – <40% = impaired function ...
... decreased ejection fraction • Ejection Fraction= percentage of blood left ventricle pumps out with each beat – Normal= 55-70% – <40% = impaired function ...
Slide 1
... “When impulses travel through the heart, electrical currents are generated that spread throughout the body. These impulses can be detected on the body surface and recorded with an ...
... “When impulses travel through the heart, electrical currents are generated that spread throughout the body. These impulses can be detected on the body surface and recorded with an ...
Cardiac resynchronization therapy for pediatric heart failure
... (⬎120 ms) despite optimal medical therapy. The pediatric heart failure population is a heterogeneous population comprising cardiomyopathy and congenital heart disease patients.1 The growing number of patients surviving surgical interventions has contributed to this heterogeneity. Current guidelines ...
... (⬎120 ms) despite optimal medical therapy. The pediatric heart failure population is a heterogeneous population comprising cardiomyopathy and congenital heart disease patients.1 The growing number of patients surviving surgical interventions has contributed to this heterogeneity. Current guidelines ...
Fortis Escorts Heart Institute implants India`s first Subcutaneous
... heart, some patients who need the ICD are not suitable for this Subcutaneous ICD. Dr. Anil Saxena, Director of Cardiac Pacing and Electrophysiology said, “S-ICD lead is implanted along the rib cage and breast bone. It is found to have success rates comparable to conventional ICDs, with lower complic ...
... heart, some patients who need the ICD are not suitable for this Subcutaneous ICD. Dr. Anil Saxena, Director of Cardiac Pacing and Electrophysiology said, “S-ICD lead is implanted along the rib cage and breast bone. It is found to have success rates comparable to conventional ICDs, with lower complic ...
Trygve Husebye 1,2,4, Jan Eritsland 1,2, Harald Arnesen 2,3,4
... (baseline), on day 1, on day 5 and after 6 weeks. PSV (mean of septal, lateral, anterior and posterior mitral annular peak systolic velocity) measured by tissue velocity imaging, and global longitudinal strain (GLS) of the left ventricle measured by speckle tracking were analyzed at all time-points. ...
... (baseline), on day 1, on day 5 and after 6 weeks. PSV (mean of septal, lateral, anterior and posterior mitral annular peak systolic velocity) measured by tissue velocity imaging, and global longitudinal strain (GLS) of the left ventricle measured by speckle tracking were analyzed at all time-points. ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.